Bahl & Gaynor’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-5,835
Closed -$256K 346
2020
Q3
$256K Hold
5,835
﹤0.01% 311
2020
Q2
$258K Sell
5,835
-30,034
-84% -$1.33M ﹤0.01% 310
2020
Q1
$1.29M Sell
35,869
-10,532
-23% -$378K 0.01% 237
2019
Q4
$3.29M Sell
46,401
-1,472
-3% -$104K 0.02% 190
2019
Q3
$3.58M Buy
47,873
+11
+0% +$823 0.03% 172
2019
Q2
$3.86M Sell
47,862
-45,768
-49% -$3.69M 0.03% 164
2019
Q1
$6.26M Buy
93,630
+3,053
+3% +$204K 0.06% 108
2018
Q4
$6.74M Buy
90,577
+11,107
+14% +$827K 0.07% 97
2018
Q3
$7.32M Buy
79,470
+13,008
+20% +$1.2M 0.09% 99
2018
Q2
$6.54M Buy
66,462
+4,628
+7% +$455K 0.07% 105
2018
Q1
$6.89M Buy
61,834
+1,850
+3% +$206K 0.08% 103
2017
Q4
$6.17M Buy
59,984
+1,735
+3% +$178K 0.06% 110
2017
Q3
$5.49M Buy
58,249
+13,712
+31% +$1.29M 0.06% 112
2017
Q2
$3.47M Buy
44,537
+3,424
+8% +$267K 0.04% 136
2017
Q1
$3.29M Buy
41,113
+3,920
+11% +$314K 0.04% 141
2016
Q4
$2.93M Buy
37,193
+4,800
+15% +$378K 0.04% 143
2016
Q3
$2.53M Buy
32,393
+2,600
+9% +$203K 0.03% 153
2016
Q2
$2.05M Buy
29,793
+1,815
+6% +$125K 0.03% 168
2016
Q1
$2M Buy
27,978
+763
+3% +$54.4K 0.03% 165
2015
Q4
$1.69M Buy
27,215
+6,522
+32% +$405K 0.02% 177
2015
Q3
$1.17M Buy
20,693
+2,990
+17% +$169K 0.02% 210
2015
Q2
$950K Buy
17,703
+790
+5% +$42.4K 0.01% 235
2015
Q1
$803K Sell
16,913
-3,530
-17% -$168K 0.01% 242
2014
Q4
$885K Sell
20,443
-5,500
-21% -$238K 0.01% 230
2014
Q3
$891K Buy
25,943
+3,345
+15% +$115K 0.01% 221
2014
Q2
$828K Hold
22,598
0.01% 227
2014
Q1
$762K Buy
22,598
+969
+4% +$32.7K 0.01% 225
2013
Q4
$733K Buy
21,629
+1,908
+10% +$64.7K 0.01% 222
2013
Q3
$628K Sell
19,721
-4
-0% -$127 0.01% 223
2013
Q2
$445K Buy
+19,725
New +$445K 0.01% 246